A plan to slash drug review times at the Food and Drug Administration is sparking deep concerns among agency staffers and ...
The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...
The Daily Overview on MSN
White House fast-tracks debt cancellation for millions, see if you qualify
The White House is accelerating a new round of student debt cancellation, aiming to wipe out balances for millions of ...
The U.S. Department of Labor announced a $98 million funding initiative designed to expand pre-apprenticeship programs and steer young Americans into high-demand industries as the Trump administration ...
According to a community announcement, the expansion is aimed at filling critical health care vacancies across Northern Michigan. More than $60,000 in scholarship support will be available in 2026, ...
South Korea’s plan to fast-track AI doctorates reflects a broader effort to strengthen its research competitiveness. Yet the initiative exposes a deeper structural problem — accelerating degrees ...
The U.S. Food and Drug Administration (FDA) is preparing to fast-track reviews of two experimental Merck & Co. Inc. (NYSE: MRK) drugs with potential blockbuster sales. Merck's cholesterol treatment ...
On Wednesday, Trump unveiled the "Trump Gold Card" and "Trump Platinum Card," two contribution-based pathways marketed as offering unprecedented access to the United States. The Trump Gold Card offers ...
Dec 9 (Reuters) - The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten review time for a drug application. The approval for the ...
FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly//File Photo Dec 9 (Reuters) - The U.S.
(RTTNews) - Cullinan Therapeutics, Inc. (CGEM) announced that the U.S. FDA has granted Fast Track Designation to CLN-049, a novel, investigational FLT3xCD3 bispecific T cell engager, for the treatment ...
As vicious infighting in President Donald Trump’s Make America Great Again movement over the controversial H-1B visa magnifies uncertainty for foreign workers in the U.S., Canada last week approved a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results